These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 2969083
1. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Invernizzi RW, Cervo L, Samanin R. Neuropharmacology; 1988 May; 27(5):515-8. PubMed ID: 2969083 [Abstract] [Full Text] [Related]
2. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Cervo L, Grignaschi G, Samanin R. Eur J Pharmacol; 1988 Dec 06; 158(1-2):53-9. PubMed ID: 2975608 [Abstract] [Full Text] [Related]
3. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons. Bendotti C, Samanin R. Eur J Pharmacol; 1986 Feb 11; 121(1):147-50. PubMed ID: 2937644 [Abstract] [Full Text] [Related]
4. Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist. Cervo L, Samanin R. Eur J Pharmacol; 1987 Dec 01; 144(2):223-9. PubMed ID: 2963752 [Abstract] [Full Text] [Related]
5. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Martin P, Beninger RJ, Hamon M, Puech AJ. Behav Brain Res; 1990 May 07; 38(2):135-44. PubMed ID: 2141988 [Abstract] [Full Text] [Related]
6. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist. Carli M, Samanin R. Psychopharmacology (Berl); 1988 May 07; 94(1):84-91. PubMed ID: 2894704 [Abstract] [Full Text] [Related]
7. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity. Hillegaart V, Hjorth S. Eur J Pharmacol; 1989 Jan 31; 160(2):303-7. PubMed ID: 2527161 [Abstract] [Full Text] [Related]
8. Dopamine receptor blockade in nucleus accumbens or caudate nucleus differentially affects feeding induced by 8-OH-DPAT injected into dorsal or median raphe. Fletcher PJ. Brain Res; 1991 Jun 28; 552(2):181-9. PubMed ID: 1833034 [Abstract] [Full Text] [Related]
9. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine. Blier P, Serrano A, Scatton B. Synapse; 1990 Jun 28; 5(2):120-33. PubMed ID: 2137943 [Abstract] [Full Text] [Related]
10. Administration of 8-hydroxy-2-(Di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. Invernizzi R, Carli M, Di Clemente A, Samanin R. J Neurochem; 1991 Jan 28; 56(1):243-7. PubMed ID: 1824782 [Abstract] [Full Text] [Related]
11. A pharmacological analysis of the eating response induced by 8-OH-DPAT injected into the dorsal raphé nucleus reveals the involvement of a dopaminergic mechanism. Fletcher PJ, Davies M. Psychopharmacology (Berl); 1990 Jan 28; 100(2):188-94. PubMed ID: 2137632 [Abstract] [Full Text] [Related]
12. 8-Hydroxy-2-(di-n-propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A receptors. Carli M, Samanin R. Br J Pharmacol; 1992 Mar 28; 105(3):720-6. PubMed ID: 1385752 [Abstract] [Full Text] [Related]
13. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ. J Pharmacol Exp Ther; 1997 Mar 28; 280(3):1241-9. PubMed ID: 9067310 [Abstract] [Full Text] [Related]
15. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function. Goodwin GM, De Souza RJ, Green AR. Neuropharmacology; 1985 Dec 28; 24(12):1187-94. PubMed ID: 2869435 [Abstract] [Full Text] [Related]
16. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Yamada J, Sugimoto Y, Horisaka K. Eur J Pharmacol; 1988 Sep 23; 154(3):299-304. PubMed ID: 2976671 [Abstract] [Full Text] [Related]
17. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Beer M, Kennett GA, Curzon G. Eur J Pharmacol; 1990 Mar 20; 178(2):179-87. PubMed ID: 1691712 [Abstract] [Full Text] [Related]
18. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat. Chaouloff F, Jeanrenaud B. J Pharmacol Exp Ther; 1987 Dec 20; 243(3):1159-66. PubMed ID: 2826757 [Abstract] [Full Text] [Related]
19. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3. Hjorth S, Sharp T, Hacksell U. Eur J Pharmacol; 1989 Nov 07; 170(3):269-74. PubMed ID: 2533557 [Abstract] [Full Text] [Related]
20. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S. Eur J Pharmacol; 1984 Oct 15; 105(3-4):365-8. PubMed ID: 6239785 [Abstract] [Full Text] [Related] Page: [Next] [New Search]